Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given with Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Trial Identifier: MEQ00064
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: March 2023
Primary Completion Date: November 2025
Study Completion Date: November 2025
Condition: Healthy Volunteers; Meningococcal Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
India Hyderabad, India, 500018
India Kanpur, India, 208002
India New Delhi, India, 110002
India Pune, India, 411043
INDIA Chennai, INDIA, 603203
INDIA Kolkata, INDIA, 700017
INDIA Manipal, INDIA, 576104
INDIA Mysore, INDIA, 570001
INDIA Mysore, INDIA, 570004
INDIA PUNE, INDIA, 411011
South Africa CAPE TOWN, South Africa, 7937
South Africa George, South Africa, 6530
South Africa Johannesburg, South Africa, 2013
SOUTH AFRICA CAPE TOWN, SOUTH AFRICA, 7505
SOUTH AFRICA Middelburg, SOUTH AFRICA, 1055